 |
 |
> Seems to me the helpfulness of biomarkers is pretty seriously limited by > the absence of treatments that will slow or reverse disease progression. > Under present conditions, biomarkers might be seen as stealing a few years > of blissful ignorance, when you don't yet know you have this disease. > > Or insurance companies might find a better way to deny coverage, or > potential employers might choose not to hire someone known to be headed for > PD. > > If someone can make a case for the value to patients of biomarkers without > better treatment, I would love to hear it. > unfortunately true maryse ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn